BCYC Bicycle Therapeutics plc

3.730USD-1.58%Mkt Cap: 260.40M $P/E: —

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's produ…

Key Statistics

Company
Market Cap260.40M USD
Enterprise Value-230.12M USD
Revenue (TTM)61.20M USD
Gross Profit-127.85M USD
Net Income (TTM)-218.96M USD
Revenue/Share0.88 USD
Last Price3.730 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees288
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.70
PEG—
EV/EBITDA1.15
EV/Revenue-3.76
P/S4.32
P/B0.52
EPS (TTM)-2.58
EPS (Forward)-2.22
52W Range
3.3307% of range9.159
52W High9.159 USD
52W Low3.330 USD
Profitability
Gross Margin-208.89%
Oper. Margin-8673.93%
EBITDA Margin0.00%
Profit Margin-301.66%
ROE-35.90%
ROA-30.51%
Growth
Revenue Growth-78.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-249.68M USD
CapEx (TTM)2.35M USD
FCF Margin-163.09%
FCF Yield-38.33%
Net Debt-495.39M USD
Net Debt/EBITDA2.47
Balance Sheet
Debt/Equity0.03
Current Ratio12.08
Quick Ratio11.70
Book Value/Sh7.31 USD
Cash/Share7.29 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.500 USD
Upside (mean)+154.7%
Target Range5.000 USD – 14.00 USD
5.000+154.7% to mean14.00
# Analysts6
Ownership
Shares Out.50.37M
Float7.78M
Insiders4.47%
Institutions72.05%
Short Interest
Short Ratio9.1d
Short % Float8.53%
Short % Out.4.76%
Shares Short3.33M
Short (prev mo.)3.22M
Technical
SMA 503.958 (-5.8%)
SMA 2004.859 (-23.2%)
Beta1.68
S&P 52W Chg16.45%
Avg Vol (30d)474.56K
Avg Vol (10d)588.42K
Technical Indicators
RSI (14)47.3
MACD-0.0858
MACD Signal-0.1052
MACD Hist.+0.0194
BB Upper4.106 USD
BB Middle3.748 USD
BB Lower3.391 USD
BB Width19.05%
ATR (14)0.2139 USD
Vol Ratio (20d)0.84x